{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:17:01Z","timestamp":1783469821466,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06085-0","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:18:17Z","timestamp":1732061897000},"page":"5371-5376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists"],"prefix":"10.1007","volume":"103","author":[{"given":"Anna R.","family":"Blankstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Mozessohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain A.","family":"Lother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette E.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Buckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"9936","key":"6085_CR1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","volume":"383","author":"L Ades","year":"2014","unstructured":"Ades L, Itzykson R, Fenaux P (2014) Myelodysplastic syndromes. Lancet Jun 28 383(9936):2239\u20132252. https:\/\/doi.org\/10.1016\/S0140-6736(13)61901-7","journal-title":"Lancet Jun 28"},{"key":"6085_CR2","unstructured":"Cancer Stat Facts (2019) Leukemia - Acute Myeloid Leukemia (AML). National Cancer Institute Surveillance, Epidemiology, and End Results Program"},{"issue":"12","key":"6085_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","volume":"35","author":"J Neukirchen","year":"2011","unstructured":"Neukirchen J, Schoonen WM, Strupp C et al (2011) Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry. Leuk Res Dec 35(12):1591\u20131596. https:\/\/doi.org\/10.1016\/j.leukres.2011.06.001","journal-title":"Leuk Res Dec"},{"key":"6085_CR4","doi-asserted-by":"publisher","unstructured":"Cazzola M, Myelodysplastic Syndromes (2020) N Engl J Med Oct 1(14):1358\u20131374. https:\/\/doi.org\/10.1056\/NEJMra1904794","DOI":"10.1056\/NEJMra1904794"},{"key":"6085_CR5","doi-asserted-by":"publisher","unstructured":"Kantarjian H, Giles F, List A et al (2007) The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. May 1.;109(9):1705-14. https:\/\/doi.org\/10.1002\/cncr.22602","DOI":"10.1002\/cncr.22602"},{"key":"6085_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.leukres.2018.12.002","volume":"76","author":"A Vijenthira","year":"2019","unstructured":"Vijenthira A, Premkumar D, Callum J et al (2019) The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: an observational single centre registry study. Leuk Res Jan 76:76\u201381. https:\/\/doi.org\/10.1016\/j.leukres.2018.12.002","journal-title":"Leuk Res Jan"},{"issue":"3","key":"6085_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/leu.2015.297","volume":"30","author":"W Li","year":"2016","unstructured":"Li W, Morrone K, Kambhampati S, Will B, Steidl U, Verma A (2016) Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies. Leuk Mar 30(3):536\u2013544. https:\/\/doi.org\/10.1038\/leu.2015.297","journal-title":"Leuk Mar"},{"issue":"3","key":"6085_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/09537100902751925","volume":"20","author":"JM Cesar","year":"2009","unstructured":"Cesar JM, Vecino AM (2009) Survival and function of transfused platelets. Studies in two patients with congenital deficiencies of platelet membrane glycoproteins. Platelets May 20(3):158\u2013162. https:\/\/doi.org\/10.1080\/09537100902751925","journal-title":"Platelets May"},{"key":"6085_CR9","doi-asserted-by":"publisher","unstructured":"Mueller MM, Van Remoortel H, Meybohm P et al (2019) Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. JAMA. Mar 12.;321(10):983\u2013997. https:\/\/doi.org\/10.1001\/jama.2019.0554","DOI":"10.1001\/jama.2019.0554"},{"issue":"4","key":"6085_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/bjh.12694","volume":"164","author":"SB Killick","year":"2014","unstructured":"Killick SB, Carter C, Culligan D et al (2014) Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol Feb 164(4):503\u2013525. https:\/\/doi.org\/10.1111\/bjh.12694","journal-title":"Br J Haematol Feb"},{"issue":"2","key":"6085_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","volume":"32","author":"P Fenaux","year":"2021","unstructured":"Fenaux P, Haase D, Santini V et al (2021) Myelodysplastic syndromes: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up(dagger\u2606). Ann Oncol Feb 32(2):142\u2013156. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.002","journal-title":"Ann Oncol Feb"},{"issue":"3","key":"6085_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjh.14423","volume":"176","author":"LJ Estcourt","year":"2017","unstructured":"Estcourt LJ, Birchall J, Allard S et al (2017) Guidelines for the use of platelet transfusions. Br J Haematol Feb 176(3):365\u2013394. https:\/\/doi.org\/10.1111\/bjh.14423","journal-title":"Br J Haematol Feb"},{"issue":"1","key":"6085_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13063-019-3663-2","volume":"15","author":"LJ Estcourt","year":"2019","unstructured":"Estcourt LJ, McQuilten Z, Powter G et al (2019) The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial. Trials Oct 15(1):592. https:\/\/doi.org\/10.1186\/s13063-019-3663-2","journal-title":"Trials Oct"},{"issue":"Supplement 1","key":"6085_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2020-138920","volume":"136","author":"TB Gernsheimer","year":"2020","unstructured":"Gernsheimer TB, Brown SP, Triulzi DJ et al (2020) Effects of Tranexamic Acid Prophylaxis on bleeding outcomes in hematologic malignancy: the a-TREAT trial. Blood 136(Supplement 1):1\u20132. https:\/\/doi.org\/10.1182\/blood-2020-138920","journal-title":"Blood"},{"issue":"1","key":"6085_CR15","doi-asserted-by":"publisher","first-page":"e2020009","DOI":"10.4084\/MJHID.2020.009","volume":"12","author":"BA Hansen","year":"2020","unstructured":"Hansen BA, Wendelbo O, Bruserud O, Hemsing AL, Mosevoll KA, Reikvam H (2020) Febrile Neutropenia in Acute Leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterr J Hematol Infect Dis 12(1):e2020009. https:\/\/doi.org\/10.4084\/MJHID.2020.009","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"6085_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1634\/theoncologist.2-6-389","volume":"2","author":"PA Kouides","year":"1997","unstructured":"Kouides PA, Bennett JM (1997) Understanding the myelodysplastic syndromes. Oncologist 2(6):389\u2013401","journal-title":"Oncologist"},{"key":"6085_CR17","doi-asserted-by":"publisher","unstructured":"Dayyani F, Conley AP, Strom SS et al (2010) Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer. May 1.;116(9):2174-9. https:\/\/doi.org\/10.1002\/cncr.24984","DOI":"10.1002\/cncr.24984"},{"issue":"4","key":"6085_CR18","first-page":"893","volume":"9","author":"K Konstantopoulos","year":"1989","unstructured":"Konstantopoulos K, Lauren L, Hast R, Reizenstein P (1989) Survival, hospitalization and cause of death in 99 patients with the myelodysplastic syndrome. Anticancer Res Jul-Aug 9(4):893\u2013896","journal-title":"Anticancer Res Jul-Aug"},{"issue":"1","key":"6085_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bjh.14033","volume":"174","author":"R Buckstein","year":"2016","unstructured":"Buckstein R, Wells RA, Zhu N et al (2016) Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study. Br J Haematol Jul 174(1):88\u2013101. https:\/\/doi.org\/10.1111\/bjh.14033","journal-title":"Br J Haematol Jul"},{"key":"6085_CR20","unstructured":"National Comprehensive Cancer Network. Myelodysplastic Syndromes (Version 3.2024). Accessed October 2 (2024) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mds.pdf"},{"key":"6085_CR21","unstructured":"National Comprehensive Cancer Network. Acute Myeloid Leukemia (Version 3.2024). Accessed October 2 (2024) https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"issue":"3","key":"6085_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1503\/cmaj.080372","volume":"29","author":"KE Burns","year":"2008","unstructured":"Burns KE, Duffett M, Kho ME et al (2008) A guide for the design and conduct of self-administered surveys of clinicians. CMAJ Jul 29(3):245\u2013252. https:\/\/doi.org\/10.1503\/cmaj.080372","journal-title":"CMAJ Jul"},{"issue":"6914","key":"6085_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/bmj.307.6914.1264","volume":"13","author":"DH Stone","year":"1993","unstructured":"Stone DH (1993) Design a questionnaire. Bmj Nov 13(6914):1264\u20131266. https:\/\/doi.org\/10.1136\/bmj.307.6914.1264","journal-title":"Bmj Nov"},{"key":"6085_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-6-5","volume":"23","author":"RA Nakash","year":"2006","unstructured":"Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE (2006) Maximising response to postal questionnaires\u2013a systematic review of randomised trials in health research. BMC Med Res Methodol Feb 23:6:5. https:\/\/doi.org\/10.1186\/1471-2288-6-5","journal-title":"BMC Med Res Methodol Feb"},{"issue":"3","key":"6085_CR25","doi-asserted-by":"publisher","first-page":"MR000008","DOI":"10.1002\/14651858.MR000008.pub4","volume":"8","author":"PJ Edwards","year":"2009","unstructured":"Edwards PJ, Roberts I, Clarke MJ et al (2009) Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev Jul 8(3):MR000008. https:\/\/doi.org\/10.1002\/14651858.MR000008.pub4","journal-title":"Cochrane Database Syst Rev Jul"},{"key":"6085_CR26","doi-asserted-by":"crossref","unstructured":"Dillman DA, Smyth JD, Christian LM (2014) Internet, phone, mail, and mixed-mode surveys: the tailored design method. Wiley","DOI":"10.1002\/9781394260645"},{"issue":"10","key":"6085_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0895-4356(97)00126-1","volume":"50","author":"DA Asch","year":"1997","unstructured":"Asch DA, Jedrziewski MK, Christakis NA (1997) Response rates to mail surveys published in medical journals. J Clin Epidemiol Oct 50(10):1129\u20131136. https:\/\/doi.org\/10.1016\/s0895-4356(97)00126-1","journal-title":"J Clin Epidemiol Oct"},{"issue":"3","key":"6085_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M14-1589","volume":"3","author":"RM Kaufman","year":"2015","unstructured":"Kaufman RM, Djulbegovic B, Gernsheimer T et al (2015) Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med Feb 3(3):205\u2013213. https:\/\/doi.org\/10.7326\/M14-1589","journal-title":"Ann Intern Med"},{"key":"6085_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/asheducation-2013.1.638","volume":"2013","author":"ZM Szczepiorkowski","year":"2013","unstructured":"Szczepiorkowski ZM, Dunbar NM (2013) Transfusion guidelines: when to transfuse. Hematol Am Soc Hematol Educ Program 2013:638\u2013644. https:\/\/doi.org\/10.1182\/asheducation-2013.1.638","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"6085_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","volume":"91","author":"VA Ferraris","year":"2011","unstructured":"Ferraris VA, Brown JR, Despotis GJ et al (2011) 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg Mar 91(3):944\u2013982. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.11.078","journal-title":"Ann Thorac Surg Mar"},{"issue":"2","key":"6085_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1606424","volume":"12","author":"PS Myles","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A et al (2017) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med Jan 12(2):136\u2013148. https:\/\/doi.org\/10.1056\/NEJMoa1606424","journal-title":"N Engl J Med"},{"key":"6085_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/ORR.S321881","volume":"13","author":"A Haratian","year":"2021","unstructured":"Haratian A, Shelby T, Hasan LK, Bolia IK, Weber AE, Petrigliano FA (2021) Utilization of Tranexamic Acid in Surgical Orthopaedic Practice: indications and current considerations. Orthop Res Rev 13:187\u2013199. https:\/\/doi.org\/10.2147\/ORR.S321881","journal-title":"Orthop Res Rev"},{"issue":"1","key":"6085_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12959-021-00303-9","volume":"11","author":"A Ockerman","year":"2021","unstructured":"Ockerman A, Vanassche T, Garip M et al (2021) Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review. Thromb J Aug 11(1):54. https:\/\/doi.org\/10.1186\/s12959-021-00303-9","journal-title":"Thromb J Aug"},{"issue":"1","key":"6085_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tmrv.2019.10.001","volume":"34","author":"BL Houston","year":"2020","unstructured":"Houston BL, Uminski K, Mutter T et al (2020) Efficacy and safety of Tranexamic Acid in Major Non-cardiac surgeries at High Risk for Transfusion: a systematic review and Meta-analysis. Transfus Med Rev Jan 34(1):51\u201362. https:\/\/doi.org\/10.1016\/j.tmrv.2019.10.001","journal-title":"Transfus Med Rev Jan"},{"issue":"6","key":"6085_CR35","doi-asserted-by":"publisher","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","volume":"14","author":"I Taeuber","year":"2021","unstructured":"Taeuber I, Weibel S, Herrmann E et al (2021) Association of Intravenous Tranexamic Acid with thromboembolic events and mortality: a systematic review, Meta-analysis, and Meta-regression. JAMA Surg Apr 14(6):e210884. https:\/\/doi.org\/10.1001\/jamasurg.2021.0884","journal-title":"JAMA Surg Apr"},{"issue":"11","key":"6085_CR36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1200\/JOP.18.00366","volume":"14","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Flowers CR (2018) Antimicrobial prophylaxis for adult patients with Cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary. J Oncol Pract Nov 14(11):692\u2013695. https:\/\/doi.org\/10.1200\/JOP.18.00366","journal-title":"J Oncol Pract Nov"},{"issue":"Suppl 1","key":"6085_CR37","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.bjc.6605270","volume":"101","author":"M Cullen","year":"2009","unstructured":"Cullen M, Baijal S (2009) Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer Sep 101(Suppl 1):S11\u2013S14. https:\/\/doi.org\/10.1038\/sj.bjc.6605270","journal-title":"Br J Cancer Sep"},{"key":"6085_CR38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178379","author":"I Chanias","year":"2023","unstructured":"Chanias I, Knecht P, Bonadies N (2023) Efficacy of primary prophylaxis in patients with MDS or AML treated with Non-intensive agents: systematic review with Meta-analysis. Blood. https:\/\/doi.org\/10.1182\/blood-2023-178379. \/11\/02\/ 2023;142:6491","journal-title":"Blood"},{"issue":"4","key":"6085_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ejh.14156","volume":"112","author":"A Mo","year":"2024","unstructured":"Mo A, Weinkove R, Wood EM et al (2024) Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: a clinical practice survey. Eur J Haematol Apr 112(4):621\u2013626. https:\/\/doi.org\/10.1111\/ejh.14156","journal-title":"Eur J Haematol Apr"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06085-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:14:13Z","timestamp":1735866853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06085-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6085"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06085-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the University of Manitoba Health Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}